Green Lizard Technologies Ltd

Back to portfolio

GLT’s primary function is to carry out innovative, industry–led research and development to provide green and sustainable solutions to industrial problems.

Green Lizard Technologies Ltd, founded in 2015, is a spin–out company from Queen’s University Belfast with the vision to provide green sustainable technological solutions to the chemical industry. 

We focus on solving immediate problems and providing a mechanism to incubate new ideas and scope new innovations in a fast and effective manner.

What makes GLT unique is our ability to identify innovative technologies and accelerate their commercialisation and deployment within the sustainable energy and chemical industries.

Working with our industrial partners and building on our academic research GLT has developed a portfolio of novel, green technologies;

  • Green glycidol
  • Triglyceride refining
  • PET recycling
  • Waste plastics recycling
  • DMC production
  • Energy storage

Key Facts

  • Over £14m invested in projects to date
  • 8 awards including IChemE ‘Best Business Start up’ Global Award 2018
  • An extensive and diverse skill–set gained in both the Chemical Industry and Academia
  • R&D carried out in Queens University Belfast with scale up and semi–commercial operations at Wilton Centre, Teesside
  • A highly experienced Board of Directors who collectively provide a range of vital skills and experience including commercialisation, entrepreneurship, leadership, financial, operational, legal, strategic planning and business development.
Visit website
  • Digital

    Eventmap Ltd

    Tailored software and consultancy packages for timetabling, scheduling, resource and space planning within the education, training and public sectors.

    Read more
  • Life Science

    Biocolor Ltd

    Biocolor designs, manufactures and distributes research tools for use by cell biology and bioengineering communities.

    Read more
  • Life Science

    ProAxsis

    ProAxsis specialises in the development and commercialisation of in vitro diagnostic laboratory assays and point–of–care tests designed to measure active protease biomarkers of disease.

    Read more
  • Life Science

    CV6 Therapeutics (NI) Ltd

    CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.

    Read more